[治疗2型糖尿病的药理疗法]
Francisco Javier García Soidán1, Javier Riveiro Villanueva2
1Centro de Salud de Porriño. Área Sanitaria de Vigo, Pontevedra.
Atencion primaria
|November 20, 2024
概括
管理2型糖尿病包括饮食,运动,教育和药物治疗. 基于证据的算法有助于根据患者因素和并发症选择最佳的抗糖尿病药物.
科学领域:
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 2型糖尿病 (T2DM) 的管理依赖于四个支柱:生活方式干预和药物治疗.
- 存在十种不同的类别的抗糖尿病药物,在机制,对体重的影响,低血糖风险和并发症减少方面有所不同.
- 个性化治疗选择至关重要,考虑到患者特异性因素和伴随性疾病,如心血管疾病,心力衰竭,慢性病,肥胖和非酒精性脂肪肝疾病.
研究的目的:
- 提出一种基于证据的工具,用于选择2型糖尿病的最佳药理疗法.
- 引导临床医生根据患者的特征和并发症个性化选择药物.
主要方法:
- 基于机制,体重效应,低血糖风险和并发症减少的十种抗糖尿病药物组的审查和分类.
- 使用RedGDPS基金会的2型糖尿病治疗算法.
- 个性化患者评估,考虑偏好,特征和特定的并发症.
主要成果:
- 该算法根据关键的药理学和临床参数对抗糖尿病药物进行分类.
- 它促进了对2型糖尿病药物选择的结构化方法.
- 该工具支持与患者个人资料一致的个性化治疗策略.
结论:
- 红GDPS基金会的治疗算法是优化2型糖尿病的药理管理的有价值的,基于证据的资源.
- 以这种算法为指导的个性化选择抗糖尿病药物可以改善患者的治疗结果.
- 有效的T2DM治疗需要全面的方法,整合生活方式和量身定制的药物治疗.
相关概念视频
01:15Diabetes: Management and Pharmacotherapy
236
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
236
01:22Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
174
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
174
01:22Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
01:36Carbohydrate Metabolism
10.8K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.8K
01:24Glucagon-like Receptor Agonists
298
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
298